Cencora Inc. logo

Cencora Inc. (COR)

Market Closed
27 Feb, 20:00
NYSE NYSE
$
372. 14
+5.49
+1.5%
$
70.24B Market Cap
- P/E Ratio
2.2% Div Yield
616,652 Volume
- Eps
$ 366.65
Previous Close
Day Range
366.87 373.98
Year Range
248.59 377.54
Want to track COR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
COR earnings report is expected in 64 days (5 May 2026)
Here's Why Cencora (COR) is a Strong Growth Stock

Here's Why Cencora (COR) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 month ago
4 Stocks Trading Near 52-Week High With More Upside Potential

4 Stocks Trading Near 52-Week High With More Upside Potential

Stocks like NVDA, RL, EXPE and COR are seeing price strength and have a high chance of carrying the momentum forward.

Zacks | 2 months ago
Cencora to Acquire OneOncology to Expand Community Oncology Solutions

Cencora to Acquire OneOncology to Expand Community Oncology Solutions

COR's $3.6 billion move to take control of OneOncology boosts its pharma-centric strategy and lifts its long-term growth outlook despite a short-term dip.

Zacks | 2 months ago
Why Cencora (COR) is a Top Growth Stock for the Long-Term

Why Cencora (COR) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 months ago
Here's Why You Should Add Cencora Stock to Your Portfolio Now

Here's Why You Should Add Cencora Stock to Your Portfolio Now

Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.

Zacks | 2 months ago
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.

Zacks | 2 months ago
Why Is Cencora (COR) Down 6.3% Since Last Earnings Report?

Why Is Cencora (COR) Down 6.3% Since Last Earnings Report?

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 months ago
Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seekingalpha | 2 months ago
Cencora (COR) Upgraded to Buy: Here's Why

Cencora (COR) Upgraded to Buy: Here's Why

Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 2 months ago
Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seekingalpha | 2 months ago
Here's Why Cencora (COR) is a Strong Value Stock

Here's Why Cencora (COR) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
Here's Why Cencora (COR) is a Strong Growth Stock

Here's Why Cencora (COR) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Loading...
Load More